SCID-PANSS: Two tier diagnostic system for psychotic disorders

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works

Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine

Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156 · see citing works

Dementia Praecox and Paraphrenia.

(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,906 · see citing works

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

Kay, S. R., Opler, L. A., & Lindenmayer, J.-P. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291514 · Cited by 1,016 · see citing works

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, S. R., Opler, L. A., & Lindenmayer, J.-P. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90038-8 · Cited by 1,007 · see citing works

Psychopharmacology. A Review of Progress, 1957-1967

Burger, A. (1969) · Journal of Medicinal Chemistry · doi:10.1021/jm00305a903 · Cited by 891 · see citing works

Part III. Speculations on the Processes That Underlie Schizophrenic Symptoms and Signs

Strauss, J., Carpenter, W. T., & Bartko, J. J. (1974) · Schizophrenia Bulletin · doi:10.1093/schbul/1.11.61 · Cited by 574 · see citing works

Pyramidical Model of Schizophrenia

Kay, S. R., & Sevy, S. M. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.537 · Cited by 444 · see citing works

Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders

van Praag, H. M. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90067-x · Cited by 264 · see citing works

Clozapine in treatment-resistant schizophrenics.

Kane, J. M., Honigfeld, G., Singer, J., & Meltzer, H. Y. (1988) · PubMed · Cited by 217 · see citing works

Significance of Positive and Negative Syndromes in Chronic Schizophrenia

Kay, S. R., Opler, L. A., & Fiszbein, A. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.4.439 · Cited by 194 · see citing works

Positive and negative syndromes in schizophrenia: Assessment and research.

Kay, S. R. (1991) · Medical Entomology and Zoology · Cited by 185 · see citing works

"Negative Symptoms": Conceptual and Methodological Problems

Sommers, A. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.364 · Cited by 180 · see citing works

Social Adjustment and Cognitive Performance of High-Risk Children

Sohlberg, S. C., & Yaniv, S. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.1.61 · Cited by 178 · see citing works

The positive-negative dimension in schizophrenia: its validity and significance.

Kay, & Opler, L. A. (1987) · PubMed · Cited by 114 · see citing works

Negative Symptoms: Are They Indigenous to Schizophrenia?

Zubin, J. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.461 · Cited by 86 · see citing works

Suggested guidelines for including or excluding categories in the DSM-IV

Blashfield, R. K., Sprock, J., & Fuller, A. K. (1990) · Comprehensive Psychiatry · doi:10.1016/0010-440x(90)90049-x · Cited by 85 · see citing works

Negative Symptomatology and Schizophrenia: A Conceptual and Empirical Review

Pogue‐Geile, M. F., & Zubin, J. (1987) · International Journal of Mental Health · doi:10.1080/00207411.1987.11449074 · Cited by 82 · see citing works

The Religious Aspect of Ulster Revivalism

M'Ilwaine, W. (1860) · Journal of Mental Science · doi:10.1192/bjp.7.35.59 · Cited by 44 · see citing works

Reliability of the structured clinical interview for DSM-iII-R: an evaluative review

Segal, D. L., Hersen, M., & Van Hasselt, V. B. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90025-6 · Cited by 293 · see citing works

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

Durgam, S., Starace, A., Li, D., Migliore, R., Ruth, A., Németh, G., & Laszlovszky, I. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.041 · Cited by 192 · see citing works

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia

Kane, J. M., Zukin, S. R., Wang, Y., Lu, K., Ruth, A., Nagy, K., Laszlovszky, I., & Durgam, S. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000346 · Cited by 177 · see citing works

Task-induced deactivation of midline cortical regions in schizophrenia assessed with fMRI

Harrison, B. J., Yücel, M., Pujol, J., & Pantelis, C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.12.027 · Cited by 166 · see citing works

A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis

White, R., Gumley, A., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., & Mitchell, G. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.09.003 · Cited by 161 · see citing works

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

Dervaux, A., Bayle, F., Laqueille, X., Bourdel, M., Borgne, M.-H. L., Olié, J., & Krebs, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.492 · Cited by 147 · see citing works

Looking at the other side of the coin: A meta-analysis of self-reported emotional arousal in people with schizophrenia

Llerena, K., Strauss, G. P., & Cohen, A. S. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.005 · Cited by 122 · see citing works

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone

Yamanouchi, Y., Iwata, N., Suzuki, T., Kitajima, T., Ikeda, M., & Ozaki, N. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500211 · Cited by 97 · see citing works

Frontal areas contribute to reduced global coordination of resting-state gamma activities in drug-naïve patients with schizophrenia

Kikuchi, M., Hashimoto, T., Nagasawa, T., Hirosawa, T., Minabe, Y., Yoshimura, M., Strik, W., Dierks, T., & Koenig, T. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.003 · Cited by 74 · see citing works

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

Cutler, A. J., Durgam, S., Wang, Y., Migliore, R., Lu, K., Laszlovszky, I., & Németh, G. (2017) · CNS Spectrums · doi:10.1017/s1092852917000220 · Cited by 70 · see citing works

Biomarkers of oxidative stress in schizophrenic and control subjects

Young, J. A., McKinney, S. B., Ross, B. M., Wahle, K. W. J., & Boyle, S. P. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.11.003 · Cited by 66 · see citing works

The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients

Good, K. P. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.07.001 · Cited by 65 · see citing works

Cariprazine in the treatment of schizophrenia

Durgam, S., Litman, R. E., Papadakis, K., Li, D., Németh, G., & Laszlovszky, I. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000110 · Cited by 65 · see citing works

Untitled work

Ekman (1993) · doi:10.1016/j.neuropsychologia.2009.11.023 · Cited by 55 · see citing works

Effects of Interrater Reliability of Psychopathologic Assessment on Power and Sample Size Calculations in Clinical Trials

Müller, M. J., & Szegedi, A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00013 · Cited by 62 · see citing works

Delirium During Acute Illness in Nursing Home Residents

Boockvar, K. S., Signor, D., Ramaswamy, R., & Hung, W. W. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.06.004 · Cited by 58 · see citing works

Personality traits, interpersonal problems and therapeutic alliance in early schizophrenia spectrum disorders

Johansen, R. E. B., Melle, I. S., Iversen, V. C., & Hestad, K. A. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.05.016 · Cited by 53 · see citing works

Duration of untreated psychosis: Impact of the definition of treatment onset on its predictive value over three years of treatment

Golay, P., Alameda, L., Baumann, P., Elowe, J., Progin, P., Polari, A. R., & Conus, P. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.017 · Cited by 50 · see citing works

Assessing Positive and Negative Symptoms in Outpatients with Schizophrenia and Mood Disorders

Purnine, D. M., Carey, K. B., Maisto, S. A., & Carey, M. P. (2000) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200010000-00003 · Cited by 45 · see citing works

Automatic language analysis identifies and predicts schizophrenia in first-episode of psychosis

Figueroa-Barra, A. I., Aguila, D. D., Cerda, M., Gaspar, P. A., Terissi, L. D., Durán, M., & Valderrama, C. (2022) · Schizophrenia · doi:10.1038/s41537-022-00259-3 · Cited by 43 · see citing works

Correlations between clinical symptoms, working memory functions and structural brain abnormalities in men with schizophrenia

Szendi, I., Kiss, M., Racsmány, M., Boda, K., Cimmer, C., Vörös, E., Kovács, Z. A., Szekeres, G., Galsi, G., Pléh, C., et al. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.05.014 · Cited by 43 · see citing works

Disrupted memory inhibition in schizophrenia

Racsmány, M., Conway, M., Garab, E. A., Cimmer, C., Janka, Z., Kurimay, T., Pléh, C., & Szendi, I. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.002 · Cited by 40 · see citing works

Depression and anxiety following psychosis: Associations with mindfulness and psychological flexibility

White, R. G., Gumley, A. I., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., & Mitchell, G. (2013) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812000239 · Cited by 37 · see citing works

Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia

Li, N., Yang, P., Tang, M., Liu, Y. H., Guo, W., Lang, B., Wang, J., Wu, H., Tang, H., Yu, Y. H., et al. (2022) · Schizophrenia · doi:10.1038/s41537-022-00214-2 · Cited by 34 · see citing works

Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naïve schizophreniform psychosis

Harrison, B. J., Yücel, M., Shaw, M. E., Brewer, W. J., Nathan, P. J., Strother, S. C., Olver, J. S., Egan, G. F., Velakoulis, D., McGorry, P. D., et al. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.02.006 · Cited by 34 · see citing works

Therapeutic alliance in early schizophrenia spectrum disorders: a cross-sectional study

Johansen, R. E. B., Iversen, V. C., Melle, I. S., & Hestad, K. A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-14 · Cited by 33 · see citing works

Identification of Candidate Single-Nucleotide Polymorphisms in NRXN1 Related to Antipsychotic Treatment Response in Patients with Schizophrenia

Jenkins, A. K., Apud, J. A., Zhang, F., Decot, H., Weinberger, D. R., & Law, A. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.65 · Cited by 31 · see citing works

Anterior cingulate activation in antipsychotic‐naïve first‐episode schizophrenia

Yücel, M., Brewer, W. J., Harrison, B. J., Fornito, A., O'Keefe, G. J., Olver, J. S., Scott, A. M., Egan, G. F., Velakoulis, D., McGorry, P. D., et al. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00902.x · Cited by 30 · see citing works

Clinical correlates of olfactory hallucinations in schizophrenia

Langdon, R. A., McGuire, J., Stevenson, R. J., & Catts, S. V. (2010) · British Journal of Clinical Psychology · doi:10.1348/014466510x500837 · Cited by 28 · see citing works

On the use of the Positive and Negative Syndrome Scale in randomized clinical trials

Nicotra, E. F., Casu, G., Piras, S., & Marchese, G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.006 · Cited by 26 · see citing works

Characterizing anterior cingulate activation in chronic schizophrenia: a group and single‐subject fMRI study

Harrison, B. J., Yücel, M., Fornito, A., Wood, S. J., Seal, M. L., Clarke, K., & Pantelis, C. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01002.x · Cited by 26 · see citing works

Increased Prefrontal Cerebral Blood flow in First-Episode Schizophrenia Following Treatment: Longitudinal Positron Emission Tomography Study

Brewer, W. J., Yücel, M., Harrison, B. J., McGorry, P. D., Olver, J. S., Egan, G. F., Velakoulis, D., & Pantelis, C. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601109899 · Cited by 25 · see citing works

Neuropsychological Characteristics Associated with Olfactory Hallucinations in Schizophrenia

Arguedas, D., Langdon, R. A., & Stevenson, R. J. (2012) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712000471 · Cited by 21 · see citing works

PANSS rater training using Internet and videoconference: Results from a pilot study

Kobak, K. A., Opler, M. G., & Engelhardt, N. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.011 · Cited by 21 · see citing works

Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping

Szendi, I., Racsmány, M., Cimmer, C., Csifcsák, G., Kovács, Z. A., Szekeres, G., Galsi, G., Tóth, F., Nagy, A., Garab, E. A., et al. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0073-6 · Cited by 21 · see citing works

Effects of sertindole on cognition in clozapine‐treated schizophrenia patients

Nielsen, R. E., Levander, S. E., Thode, D., & Nielsen, J. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01840.x · Cited by 19 · see citing works

Procedural memory in schizophrenia assessed using a mirror reading task

Takano, K., Ito, M., Kobayashi, K., 園部, 夏., 黒須, 貞., Mori, Y., Takeuchi, S., Uchiyama, M., Kanno, M., & Niwa, S. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00021-5 · Cited by 19 · see citing works

Perspectives on the Positive and Negative Syndrome Scale (Panss): Use, Misuse, Drawbacks, and A New Alternative for Schizophrenia Research

Aboraya, A., & Nasrallah, H. A. (2016) · Annals of Clinical Psychiatry · doi:10.1177/104012371602800206 · Cited by 46 · see citing works

Cognitive function, treatment response to lithium, and social functioning in Japanese patients with bipolar disorder

Saitô, S., Fujii, K., Ozeki, Y., Ohmori, K., Honda, G., Mori, H., Kato, K., Kuroda, J., Aoki, A., Asahi, H., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12521 · Cited by 16 · see citing works

Visual-feedback therapy for antipsychotic medication adherence

Kozuki, Y., & Schepp, K. G. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000177016.59484.ce · Cited by 16 · see citing works

ADHERENCE AND NONADHERENCE TO ANTIPSYCHOTIC MEDICATIONS

Kozuki, Y., & Schepp, K. G. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840590922425 · Cited by 16 · see citing works

Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study

Cai, H., Zeng, C., Zhang, X., Liu, Y., Wu, R., Guo, W., Wang, J., Wu, H., Tang, H., Ge, X., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114762 · Cited by 15 · see citing works

Migration in patients with early psychosis: A 3-year prospective follow-up study

Golay, P., Baumann, P., Jaton, L., Restellini, R., Solida, A., Mebdouhi, N., & Conus, P. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.021 · Cited by 15 · see citing works

Acceptance and Commitment Therapy for depression following psychosis: An examination of clinically significant change

White, R. G., Gumley, A. I., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., McLeod, H. J., & Mitchell, G. (2015) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2015.06.004 · Cited by 13 · see citing works

BMI-NECK: A simple assessment of risk of obstructive sleep apnea in schizophrenia

Szaulińska, K., & Wichniak, A. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.03.005 · Cited by 12 · see citing works

Age at the time of onset of psychosis: A marker of specific needs rather than a determinant of outcome?

Golay, P., Alameda, L., Mebdouhi, N., Baumann, P., Ferrari, C., Solida, A., Progin, P., Elowe, J., & Conus, P. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.06.002 · Cited by 11 · see citing works

Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6)

Kølbæk, P., Dines, D., Hansen, J., Opler, M. G. A., Correll, C. U., Mors, O. N., & Østergaard, S. D. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.044 · Cited by 10 · see citing works

Comparison of the effects of Sertindole and Olanzapine on Cognition (SEROLA): a double-blind randomized 12-week study of patients diagnosed with schizophrenia

Nielsen, R. E., Odur, F., Østergaard, T., Munk‐Jørgensen, P., & Nielsen, J. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313499065 · Cited by 9 · see citing works

Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale

Du, C., Chen, J., Ma, X., Tu, W., Chen, L., Liu, J., Zhou, D., Chen, X., Zhang, J., Tian, H., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.992745 · Cited by 9 · see citing works

Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation

Ivashchenko, D. V., Khoang, S. Z. K., Makhmudova, B. V., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Akmalova, K. A., Шуев, Г. Н., Dorina, I. V., Nastovich, M. I. N., et al. (2020) · Drug metabolism and drug interactions · doi:10.1515/dmpt-2020-0102 · Cited by 9 · see citing works

Abnormal connectivity and activation during audiovisual speech perception in schizophrenia

Hirano, Y., Nakamura, I., & Tamura, S. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16183 · Cited by 4 · see citing works

Validation of the Five-Factor Model of the Arabic Version of the Positive and Negative Syndrome Scale in Schizophrenia

Yehya, A., Ghuloum, S., Mahfoud, Z. R., Opler, M. G., Khan, A., Hammoudeh, S., Hani, Y., & Al-Amin, H. A. (2017) · Psychopathology · doi:10.1159/000472154 · Cited by 8 · see citing works

The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study

Ivashchenko, D. V., Khoang, S. Z. K., Tazagulova, M. K., Makhmudova, B. V., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Dorina, I. V., Nastovich, M. I. N., Akmalova, K. A., et al. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-5-24-31 · Cited by 7 · see citing works

Symptom dimensions stability over time in recent onset psychosis: A prospective study

Golay, P., Ramain, J., Empson, L. A., Mebdouhi, N., Elowe, J., Solida, A., & Conus, P. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.06.019 · Cited by 6 · see citing works

Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder

Brunette, M. F., Roth, R. M., Trask, C. L., Khokhar, J. Y., Ford, J., Park, S. H., Hickey, S. M., Zeffiro, T. A., & Xie, H. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae097 · Cited by 6 · see citing works

Electrophysiological Studies of Reception of Facial Communication in Autism Spectrum Disorder and Schizophrenia

Levy, E. J., Isenstein, E. L., Foss‐Feig, J. H., Srihari, V. H., Anticevic, A., Naples, A. J., & McPartland, J. C. (2021) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-021-00260-z · Cited by 7 · see citing works

A novel approach to measuring response and remission in schizophrenia in clinical trials

Aboraya, A., Leucht, S., Nasrallah, H. A., Samara, M. T., Haro, J. M., Ahmed, E., & Zangeneh, M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.020 · Cited by 6 · see citing works

HETEROGENEITY OF TREATMENT EFFECTS IN LONG-ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS

Stroup, T., Bareis, N., Rosenheck, R. A., Swartz, M., & Mcevoy, J. (2018) · Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12109 · Cited by 5 · see citing works

Cross-Validation of the Arabic Mini International Neuropsychiatric Interview, Module K, for Diagnosis of Schizophrenia and the Arabic Positive and Negative Syndrome Scale

Chamali, R., Ghuloum, S., Sheehan, D. V., Mahfoud, Z. R., Yehya, A., Opler, M. G., Khan, A., Hammoudeh, S., Hani, Y., & Al-Amin, H. A. (2019) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-019-09759-6 · Cited by 5 · see citing works

Genome Sequencing of Consanguineous Family Implicates Ubiquitin-Specific Protease 53 (USP53) Variant in Psychosis/Schizophrenia: Wild-Type Expression in Murine Hippocampal CA 1–3 and Granular Dentate with AMPA Synapse Interactions

Kanwal, A., Sheikh, S. A., Aslam, F., Yaseen, S., Beetham, Z., Pankratz, N., Clabots, C., Naz, S., & Pardo, J. V. (2023) · Genes · doi:10.3390/genes14101921 · Cited by 4 · see citing works

Physical exercise activity in individuals with schizophrenia

Bassilios, B. (2005) · Minerva Access (University of Melbourne) · Cited by 4 · see citing works

Preliminary studies on apparent mendelian psychotic disorders in consanguineous families

Kanwal, A., Sheikh, S. A., Iftikhar, A., Naz, S., & Pardo, J. V. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04304-4 · Cited by 4 · see citing works

Comorbidities in Schizophrenia: Challenges for Researchers and Clinicians

Opler, L. A., Hwang, M. Y., & Opler, M. G. A. (2013) · Psychiatric Annals · doi:10.3928/00485713-20131003-03 · Cited by 3 · see citing works

LA GESTIÓN TEMÁTICA COMO MARCADOR DE DÉFICIT LINGÜÍSTICO PRIMARIO EN PERSONAS CON DIAGNÓSTICO DE PRIMER EPISODIO DE ESQUIZOFRENIA: UN ESTUDIO EN UNA MUESTRA CHILENA

Figueroa-Barra, A. I., Durán, E., & Oyarzún, S. (2017) · RLA. Revista de lingüística teórica y aplicada · doi:10.4067/s0718-48832017000100117 · Cited by 3 · see citing works

Rare Homozygous Variants in INSR and NFXL1 Are Associated with Severe Treatment-Resistant Psychosis

Kanwal, A., Zulfiqar, R., Cheema, H. A., Jabbar, N., Iftikhar, A., Butt, A. I., Sheikh, S., Pardo, J. V., & Naz, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104925 · Cited by 1 · see citing works

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes

Ivashchenko, D. V., Yudelevich, D. A., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Akmalova, K. A., Kachanova, A. A., Dorina, I. V., Nastovich, M. I. N., Гришина, Е. А., et al. (2021) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2021-0124 · Cited by 2 · see citing works

Schizophrenia and Nicotine - A Bittersweet Psychiatric Story

Ghosal, S., Halder, A., Keshri, S., Ravindran, N. P., & Joshi, A. (2024) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_144_23 · Cited by 2 · see citing works

ENHANCED FRONTAL PROCESSING OF AUDITORY STIMULI IN SIBLINGS WITH ACUTE PSYCHOSIS

Valkonen‐Korhonen, M., Laukkanen, E., Tarkka, I. M., Partanen, J. V., & Lehtonen, J. (2003) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200301000-00012 · Cited by 2 · see citing works

índices de estereotipia verbal en textos escritos por personas con diagnóstico de esquizofrenia

Figueroa-Barra, A. I., & Herrera, C. J. M. (2021) · Literatura y lingüística · doi:10.29344/0717621x.44.2371 · Cited by 1 · see citing works

The polymorphic variants DRD2, DRD3, and DRD4 are associated with early efficacy and safety of antipsychotics in adolescents with an acute psychotic episode

Ivashchenko, D. V., Fedina, L. V., Yudelievich, D. A., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Dorina, I. V., Akmalova, K. A., Kachanova, A. A., Гришина, Е. А., et al. (2021) · Clinical pharmacology and therapy · doi:10.32756/0869-5490-2021-2-75-80 · Cited by 1 · see citing works

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes

Ivashchenko, D. V., Yudelevich, D. A., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Akmalova, K. A., Kachanova, A. A., Dorina, I. V., Nastovich, M. I. N., Гришина, Е. А., et al. (2021) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmdi-2021-0124 · Cited by 1 · see citing works

Exploring Glial Marker Activation and Neuroinflammation in Schizophrenia: A multimodal Approach

Brecke, V. (2019) · NORA - Norwegian Open Research Archives

Examination of heterogeneity in treatment response to antipsychotic medications

Bareis, N., & Stroup, T. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.033

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes

Ivashchenko, D. V., Osipov, A. S., Nazarova, E. V., Ovchinnikova, M. A., Buromskaya, N. I., Vv, S., Викторович, Ш. П., Deitch, R. V., Fainshtein, T. A., Shagovenko, E. N., et al. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-6-11-18

Analysis of associations between pharmacodynamic genetic factors and antipsychotics’ effectiveness and safety in adolescents with acute psychotic episodes taking antipsychotics during a 28-day follow-up

Ivashchenko, D. V., Fedina, L. V., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Nastovich, M. I. N., Akmalova, K. A., Kachanova, A. A., Гришина, Е. А., Savchenko, L. M., et al. (2021) · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · doi:10.37489/2588-0519-2021-2-78-88

Associations of CYP2D6, ABCB1 2677G>T/A and 3435C>T with effectiveness and safety of pharmacotherapy for acute psychotic episodes in adolescents over 28 days

Ivashchenko, D. V., Buromskaya, N. I., Викторович, Ш. П., Deitch, R. V., Nastovich, M. I. N., Akmalova, K. A., Kachanova, A. A., Гришина, Е. А., Savchenko, L. M., Shevchenko, Y. S., et al. (2021) · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · doi:10.37489/2588-0519-2021-3-39-49

Correlates and trajectories of alcohol and cannabis misuse in the early phase of psychosis: Do we need substance specific interventions?

Spanevello, C., Alameda, L., Solida, A., Empson, L. A., Alerci, L., Mebdouhi, N., Conchon, C., Vieira, S., Golay, P., & Conus, P. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.09.020

Métodos e instrumentos de evaluación utilizados en el diagnóstico del constructo "esquizofrenia".

Blázquez, B. T., & Pareja, F. J. P. (1998) · Psicologia.com

Durées d'hospitalisation des patients souffrant d'un premier épisode psychotique : déterminants et conséquences cliniques et organisationnelles

Capdevielle, D. (2010) · doi:10.70675/12cef6aez6e59z4218za642z03d83a26d4bb

A rare missense variant in Bruton's tyrosine kinase is associated with bipolar disorder accompanied by psychosis.

Kanwal, A., Cheema, H. A., Jabbar, N., Iftikhar, A., Pardo, J. V., & Naz, S. (2026) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000422

A CLN8 biallelic missense variant causes epilepsy with severe treatment-resistant psychosis

Zulfiqar, R., Kanwal, A., Hameed, M., Iftikhar, A., Seo, G. H., & Naz, S. (2026) · Molecular Genetics and Genomics · doi:10.1007/s00438-026-02480-6

CPAN: Validation of a novel transdiagnostic dimensional psychosis rating scale

Hermán, L., Vass, E., & Réthelyi, J. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.422

Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM‐5 ( SCID )

Shankman, S. A., Funkhouser, C. J., Klein, D. N., Davila, J., Lerner, D., & Hee, D. (2017) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1590 · Cited by 259 · see citing works

The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation

Hatton, C., Haddock, G., Taylor, J. L., Coldwell, J. B., Crossley, R., & Peckham, N. G. (2005) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2005.00696.x · Cited by 61 · see citing works

[The PANSS (Positive And Negative Symptom) Scale].

Guelfi, J. (1997) · PubMed · Cited by 8 · see citing works

The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum.

A, S., A, B., P, R., S, B., Gonnelli, C., Doria, M. R., L, R., Spagnolli, S., L, R., F, R., et al. (2005) · CINECA IRIS Institutial research information system (University of Pisa)